Revenue | ₹23.58Cr |
Net Profits | ₹5.05Cr |
Net Profit Margins | 21.42% |
Indo US Bio-Tech Ltd’s revenue jumped 6.26% since last year same period to ₹23.58Cr in the Q3 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 6.26% jump in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit jumped 37.23% since last year same period to ₹5.05Cr in the Q3 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 15.83% jump in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin jumped 29.14% since last year same period to 21.42% in the Q3 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 9% jump in its net profit margins since last 3-months.
The revenue for Indo US Bio-Tech Ltd in the Q3 results 2024 was ₹23.58Cr.
The net profit for Indo US Bio-Tech Ltd in the Q3 results 2024 was ₹5.05Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q3 results 2024 was 21.42%.
The revenue for Indo US Bio-Tech Ltd in the Q3 results 2023 was ₹22.19Cr.
The net profit for Indo US Bio-Tech Ltd in the Q3 results 2023 was ₹3.68Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q3 results 2023 was 16.58%.